Showing results (241-250 of 447) with videos related to

Sort By:
Pageof 45
Circulation. Arrhythmia and Electrophysiology|April 6, 2018
Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia PacingMatthew T Bennett, Nathan Leader, John Sapp, et al.
Circulation. Heart Failure|July 31, 2015
Clinical Risk Stratification for Primary Prevention Implantable Cardioverter DefibrillatorsDouglas S Lee, Judy Hardy, Raymond Yee, et al.
CJC Open|September 30, 2020
Rate, Time Course, and Predictors of Implantable Cardioverter Defibrillator Infections: An Analysis From the SIMPLE TrialFrançois Philippon, Gilles E O'Hara, Jean Champagne, et al.
Heart Rhythm|January 18, 2025
Clinical significance of a new diagnosis of atrial fibrillation in patients with vascular diseaseAlexander P Benz, Marco Alings, Jacqueline Bosch, et al.
JAMA Cardiology|April 24, 2024
Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction: A Systematic Review and Meta-AnalysisAlireza Oraii, William F McIntyre, Ratika Parkash, et al.
Circulation|June 6, 2019
Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery DiseaseKelley R Branch, Jeffrey L Probstfield, John W Eikelboom, et al.
Thrombosis and Haemostasis|September 28, 2012
Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapyRobby Nieuwlaat, Lowiek M Hubers, Alex C Spyropoulos, et al.
Circulation|August 30, 2016
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial FibrillationJonas Oldgren, Ziad Hijazi, Johan Lindbäck, et al.
Circulation. Heart Failure|October 29, 2021
Sex-Specific Clinical Outcomes of the PACT-HF Randomized TrialHarriette G C Van Spall, Ersilia M DeFilippis, Shun Fu Lee, et al.
American Heart Journal|January 16, 2023
Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trialKelley R H Branch, Jeffrey L Probstfield, Jackie Bosch, et al.
Pageof 45